Overall Survival in Patients with Multiple Myeloma in the US: A Systematic Literature Review of Racial Disparities

Multiple myeloma (MM) is a hematologic malignancy characterized by the proliferation of malignant plasma cells in the bone marrow that presents clinically with a range of symptoms, including skeletal lesions, renal insufficiency, anemia, and hypercalcemia. 1 MM is considered a rare cancer, accounting for just 10% of hematological malignancies in the United States (US). 2,3 It was estimated that 34,470 new MM cases and 12,640 deaths in the US in 2022 would be attributable to MM.4 MM primarily affects older individuals ( ≥70 years) and is more common in men.

Source: Clinical Lymphoma, Myeloma and Leukemia - October 9, 2023 Category: Hematology Authors: Joseph Mikhael, Allie Cichewicz, Elizabeth S. Mearns, Allicia Girvan, Vicki Pierre, Neda Al Rawashdh, Archibong Yellow-Duke, R. Frank Cornell, Michael Nixon Tags: Review Article Source Type: research